Innovative Grants

The purpose of each grant is to support a highly innovative pilot study at the cutting-edge, to provide the critical data required to apply for funding from larger funding organisations.

Eligibility

  • Principal Applicants must be based at a university, postgraduate institute, medical school, NHS trust or Health Board in the UK or other British Islands
  • However, co-applicants and collaborators may be based at institutions outside the UK
  • Principal Applicants must hold an employment contract at the institution that they are applying from, which covers the proposed duration of the grant
  • Applications for any one grant round will be restricted to one per principal applicant
  • If the project requires ethical approval, the award is dependent upon the requisite approvals being granted

What is offered

Innovative Grants provide up to £10,000 over a maximum of twelve months.

  • The charity will only fund direct costs in line with the AMRC policy. This may include: salaries (applicants, scientific/technical assistant but excluding PhD students), material and consumables, collaborative travel and essential equipment. All costs must be fully justified within the application
  • The charity will consider “top up” funding, when a grant is awarded to supplement funds that have already been secured by another funder in order to support ambitious projects.
  • This scheme is not designed to cover phase II/III clinical trials and drug discovery or development
  • The charity does not fund animal research

How to apply

The application process consists of two stages.  In the first stage an expression of interest is submitted, in the form of a short outline application.  Successful applicants at this stage will be invited to Stage 2 and asked to complete a more detailed application. Please read the following Royal Osteoporosis Society documents before completing a full Stage 1 application:

All our grants are reviewed by people affected by osteoporosis, so we recommend applicants involve the perspective of people affected by the condition in developing their application and have a clear plan for public and patient involvement and engagement (PPIE), for the best chance of success.

The indicative costs section is intended to be an approximation and does not require institutional approval at this stage. However, please ensure that the costs are realistic as large differences between Stage 1 and 2 applications may reduce the likelihood of the Stage 2 application being funded.

Applications must be made on the official Stage 1 application form and must be submitted electronically to research@theros.org.uk prior to the submission deadline.

Useful downloads:

Deadlines and key dates
Innovative Grant scheme launch April 6 2021
Stage 1 application submission deadline

June 7 2021

Applicants will be notified of a Stage 1 decision in July 2021

Stage 2 application submission deadline

September 14 2021

Applicants will be notified of a final decision in December 2021

NIHR Non-commercial Partner

The studies that we fund may be eligible to access the NIHR Study Support Service which is provided by the NIHR Clinical Research Network (CRN). Find out more here.

Contact details

  • If you have any questions relating to the scheme or your eligibility for the scheme please call 01761 473125 or email research@theros.org.uk 

We influence and shape policy and practice at every level through our work with healthcare professionals and policy-makers.

How you can help